Stockscreener 앱 받기
0.8892
0.02%
0.0081
Senti Biosciences Inc 주식(SNTI)의 최신 뉴스
Is Senti Biosciences Inc stock good for income investorsTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference - Bitget
Senti Bio brings early AML cell therapy data to Innate Killer meeting - Stock Titan
SNTI Stock Price, Quote & Chart | SENTI BIOSCIENCES INC (NASDAQ:SNTI) - ChartMill
Senti Biosciences Amends Lease, Restructures GeneFab Sublease - TipRanks
Senti Biosciences (NASDAQ: SNTI) halves Alameda space and resets lease with GeneFab - Stock Titan
Senti Biosciences, Inc. Enters Lease Amendment and Sublease Amendment with 1430 South Loop Owner, LLC and Genefab, LLC - marketscreener.com
Gains Report: Is Senti Biosciences Inc stock good for income investors2026 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn
Macro Review: Does Senti Biosciences Inc have a sustainable dividendQuarterly Growth Report & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Should I trade or invest in Senti Biosciences Inc2026 Pullback Review & High Yield Equity Trading Tips - baoquankhu1.vn
Senti Biosciences (SNTI) Stock Analysis Report | Financials & Insights - Benzinga España
Senti Biosciences Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Senti Biosciences (SNTI) officer has 10,757 shares withheld for taxes - Stock Titan
Senti Biosciences (SNTI) CEO reports 80,666-share tax withholding on RSUs - Stock Titan
Senti Biosciences Inc (SNTI) DEC/2025 Earning Prediction - Intellectia AI
Is Senti Biosciences Inc. stock a buy before product launchesWeekly Risk Report & Low Volatility Stock Recommendations - Naître et grandir
Risk Off: Is Senti Biosciences Inc stock good for income investorsJuly 2025 Levels & Growth Focused Stock Reports - baoquankhu1.vn
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference - Bitget
Miami healthcare conference talk from Senti Bio CEO will be webcast live - Stock Titan
SNTI PE Ratio & Valuation, Is SNTI Overvalued - Intellectia AI
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Senti Bio joins Cell & Gene Live cell therapy webinar - National Today
SNTI Should I Buy - Intellectia AI
Senti Biosciences (NASDAQ:SNTI) Shares Up 1.6% – Should You Buy? - Defense World
Senti Bio Participates in Cell & Gene Live Event on Innovative Therapies - Intellectia AI
Senti Biosciences to Showcase Gene Circuit Technology and Partnership Opportunities at TD Cowen Health Care Conference - Quiver Quantitative
Senti Bio CEO to highlight gene circuit pipeline at TD Cowen conference - Stock Titan
Senti Biosciences: A Waiting Game for Investors () - aktiencheck.de
Can Senti Biosciences Inc. sustain its profitability2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development - The Manila Times
How a cell therapy event spotlighted Senti Bio’s ‘logic-gated’ treatments - Stock Titan
Senti Biosciences reports promising phase 1 trial results - MSN
Will Senti Biosciences Inc. be affected by tariffsJuly 2025 Sector Moves & Verified Momentum Watchlists - mfd.ru
Senti Biosciences Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Insider Trends: What are the analyst revisions for Senti Biosciences IncIs ICON stock a good investment in YEARJuly 2025 Spike Watch & Accurate Trade Setup Notifications - baoquankhu1.vn
Published on: 2026-02-16 00:06:47 - mfd.ru
Can Senti Biosciences Inc. deliver alphaTrade Signal Summary & Daily Entry Point Trade Alerts - mfd.ru
Senti Biosciences completes enrollment in Phase 1 clinical trial of Senti-202 - marketscreener.com
Senti Biosciences Completes Enrollment In Phase 1 Clinical Trial Of Senti-202 - TradingView
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - The Manila Times
Leukemia cell therapy SENTI-202 heads for FDA talks after early remissions - Stock Titan
Does Senti Biosciences Inc. have a sustainable dividendShare Buyback & Smart Allocation Stock Tips - mfd.ru
Retail Surge: Is FONR benefiting from interest rate changesIPO Watch & Weekly Sector Rotation Insights - baoquankhu1.vn
Gains Recap: Does Senti Biosciences Inc have a sustainable dividendMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Aug Mood: Should I trade or invest in Senti Biosciences IncInsider Selling & AI Forecast Swing Trade Picks - baoquankhu1.vn
Growth Value: What are the analyst revisions for Senti Biosciences IncIs ICON stock a good investment in YEAR2025 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Movers: Does Senti Biosciences Inc have a sustainable dividend2025 Winners & Losers & Verified Momentum Stock Alerts - baoquankhu1.vn
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - The Manila Times
Inside Senti Bio’s 8-minute gene circuit pitch at Taipei’s 2026 healthcare conference - Stock Titan
Insider Buy: Is Senti Biosciences Inc stock good for income investorsJuly 2025 Update & Growth Oriented Trading Recommendations - baoquankhu1.vn
US Market Recap: Will EQT Corporation stock go up in YEARPortfolio Value Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Senti Biosciences Inc sustain its profitability2025 Year in Review & Verified Momentum Stock Ideas - baoquankhu1.vn
Market Rankings: Is Senti Biosciences Inc benefiting from innovation trendsJuly 2025 Outlook & Technical Entry and Exit Tips - baoquankhu1.vn
Block Trades: Is Senti Biosciences Inc benefiting from innovation trendsInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
0.99%
3.03%
자본화:
|
볼륨(24시간):